Skip to main content
. 2007 Sep 15;65(3):347–354. doi: 10.1111/j.1365-2125.2007.03015.x

Figure 2.

Figure 2

Rac-perhexiline (PHX) maleate maintenance dosage regimen, CYP2D6 genotype and plasma (+)- (○) and (−)-PHX (Inline graphic) concentration–time profiles for the six extensive metabolizer (EM) patients. Note that the time axis is dependent on the dosage regimen